Related Experiment Video
Updated: Mar 17, 2026
10:46
Corneal Donor Tissue Preparation for Descemet's Membrane Endothelial Keratoplasty
Published on: September 17, 2014
15.8K
[Descemet Membrane Endothelial Keratoplasty].
N Luft1, M Dirisamer2, S Priglinger2
1Augenklinik, Kepler Universitätsklinikum (KUK), Linz, Österreich.
Klinische Monatsblatter Fur Augenheilkunde
|July 26, 2016
Summary
Descemet membrane endothelial keratoplasty (DMEK) offers superior visual outcomes and fewer complications than DSAEK for corneal endothelial disease. Further research is needed to address challenges like graft detachment and fully establish DMEK as the standard of care.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Transplantation
Background:
- Descemet membrane endothelial keratoplasty (DMEK) is increasingly recognized for treating corneal endothelial diseases like Fuchs' dystrophy.
- Compared to Descemet stripping automated endothelial keratoplasty (DSAEK), DMEK shows potential for better visual rehabilitation and lower complication rates.
- Advancements in DMEK include standardized "no touch" techniques and pre-cut grafts from eye banks.
Purpose of the Study:
- To review the current literature on Descemet membrane endothelial keratoplasty (DMEK).
- To highlight the advantages of DMEK over other posterior lamellar keratoplasty techniques.
- To identify remaining challenges and areas for future research in DMEK.
Main Methods:
- Literature review of current studies on Descemet membrane endothelial keratoplasty (DMEK).
- Comparative analysis of DMEK versus Descemet stripping automated endothelial keratoplasty (DSAEK).
- Identification of recent technical advancements and common complications in DMEK.
Main Results:
- DMEK demonstrates superior visual rehabilitation and lower complication rates compared to DSAEK.
- Standardized "no touch" techniques and pre-cut grafts are improving DMEK accessibility.
- Graft detachment remains a significant complication requiring further investigation.
Conclusions:
- DMEK is a highly effective treatment for corneal endothelial disease, surpassing DSAEK in outcomes.
- Ongoing technical refinements and eye bank support facilitate DMEK adoption.
- Prospective-randomized studies are essential to confirm DMEK's superiority and address complications like graft detachment.
